Dr. Chu specializes in the treatment of colorectal and gastrointestinal cancers. His clinical and translational research efforts have focused on identifying novel drugs and treatment regimens for colorectal and other GI cancers. He also has a strong interest in integrating Chinese herbal medicine with standard cancer chemotherapy, with the goal of enhancing clinical activity and reducing the toxicity associated with chemotherapy.
Dr. Chu's basic research interests have focused on characterization of the molecular mechanisms underlying the development of cellular drug resistance, especially as it relates to the fluoropyrimidine class of anticancer agents.
Dr. Chu is board-certified in internal medicine and medical oncology. He received his medical degree from Brown University School of Medicine and completed a residency at Roger Williams General Hospital, Brown University, Providence, R.I., and a fellowship at the National Cancer Institute, National Institute of Health, Bethesda, Md.
Dr. Chu is a member of several professional and scientific associations, including American Society of Clinical Oncology, European Society of Medical Oncology, American Association for Cancer Research, American Association for the Advancement of Science, and American College of Physicians.